Report cover image

Global Injection Pen Market 2024-2028

Publisher TechNavio
Published Oct 12, 2023
Length 172 Pages
SKU # INF18267365

Description

Global Injection Pen Market 2024-2028


The injection pen market is forecasted to grow by USD 25.51 bn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the injection pen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, the growing prevalence of diabetes cases, and the growing popularity of injectable therapies.

Technavio's injection pen market is segmented as below:

By Product
  • Growth hormone
  • Diabetes
  • Fertility
  • Osteoporosis
  • Others
By Type
  • Disposable injection pen
  • Reusable injection pen
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the significant rise in demand for insulin pens as one of the prime reasons driving the injection pen market growth during the next few years. Also, increasing injection pen product launches by market vendors and rise in commercial approvals of new products will lead to sizable demand in the market.

The report on the injection pen market covers the following areas:
  • Injection pen market sizing
  • Injection pen market forecast
  • Injection pen market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injection pen market vendors that include AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gan and Lee Pharmaceuticals Co. Ltd., Gerresheimer AG, GlaxoSmithKline Plc, Harro Hofliger GmbH, Haselmeier GmbH, Jiangsu Delfu medical device Co. Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Pfizer Inc., Sanofi, Solteam Electronics Co LTD., Viatris Inc., and Ypsomed Holding AG. Also, the injection pen market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth

Table of Contents

172 Pages
    • Market overview
    • Market ecosystem
    • Market definition
    • Market segment analysis
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
    • Global injection pen market 2018 - 2022
    • Product Segment Analysis 2018 - 2022
    • Type Segment Analysis 2018 - 2022
    • Geography Segment Analysis 2018 - 2022
    • Country Segment Analysis 2018 - 2022
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
    • Market segments
    • Comparison by Product
    • Growth hormone - Market size and forecast 2023-2028
    • Diabetes - Market size and forecast 2023-2028
    • Fertility - Market size and forecast 2023-2028
    • Osteoporosis - Market size and forecast 2023-2028
    • Others - Market size and forecast 2023-2028
    • Market opportunity by Product
    • Market segments
    • Comparison by Type
    • Disposable injection pen - Market size and forecast 2023-2028
    • Reusable injection pen - Market size and forecast 2023-2028
    • Market opportunity by Type
    • Customer landscape overview
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2023-2028
    • Europe - Market size and forecast 2023-2028
    • Asia - Market size and forecast 2023-2028
    • Rest of World (ROW) - Market size and forecast 2023-2028
    • US - Market size and forecast 2023-2028
    • China - Market size and forecast 2023-2028
    • Canada - Market size and forecast 2023-2028
    • Germany - Market size and forecast 2023-2028
    • UK - Market size and forecast 2023-2028
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Impact of drivers and challenges
    • Market trends
    • Overview
    • Vendor landscape
    • Landscape disruption
    • Industry risks
    • Vendors covered
    • Market positioning of vendors
    • AstraZeneca Plc
    • Becton Dickinson and Co.
    • Biocon Ltd.
    • Eli Lilly and Co.
    • F. Hoffmann La Roche Ltd.
    • Gerresheimer AG
    • GlaxoSmithKline Plc
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk AS
    • Owen Mumford Ltd.
    • Pfizer Inc.
    • Sanofi
    • Viatris Inc.
    • Ypsomed Holding AG
    • Scope of the report
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.